Insider Trading History of Kumar Neil


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kumar Neil since year 2005. The trader's CIK number is 1742485. At the time of the last reporting, Kumar Neil was the Chief Executive Officer of Eidos Therapeutics, Inc. . (stock ticker symbol EIDX). See this page for all insider trading activities at Eidos Therapeutics, Inc. .

Note that in the past Kumar Neil also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kumar Neil since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-07-03 EIDX Eidos Therapeutics, Inc. Buy 882,353 29.90 26,383,237
2019-07-01 BBIO Bridgebio Pharma, Inc. Option Ex 8,952,428 .00 0
2019-05-24 EIDX Eidos Therapeutics, Inc. Buy 1,103,848 25.93 28,622,778
2018-06-22 EIDX Eidos Therapeutics, Inc. Buy 1,000,000 17.00 17,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kumar Neil (Chief Executive Officer of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.